This report provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hypertrophy/hyperplasia (BPH). These implants are reversible solutions for men suffering from lower urinary tract symptoms (LUTS) caused by prostate enlargement.
This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into:
- Unit volumes from 2022 to 2027
- Market forecasts from 2022 to 2027
- Competitive landscape analysis of major competitors
- Insights into key market events for strategics and startups
Companies Mentioned
- Butterly Medical
- Endotherapeutics
- Olympus
- ProArc
- ProVerum
- Teleflex
- Urotronic
- ZenFlow
